Ketamine combined with psychotherapy is emerging as a novel clinical treatment for severe chronic nerve pain, according to medical professionals and patients who have undergone clinical trials. For 63-year-old Carmelina Crudo of Bolton, who spent decades taking 52 pills a day for conditions including a spine injury, fibromyalgia, and Lyme disease, the experimental combination therapy offered relief after two decades of constant distress.
Understanding Ketamine and Pain Management
Ketamine functions primarily as a general anesthetic for humans and animals in Canada. According to medical professionals, the substance can be administered off-label in specialized clinical settings to manage specific mental health conditions and chronic pain disorders. A related derivative known as esketamine received approval from Health Canada in 2020 as a prescription nasal spray intended for treatment-resistant depression.
While clinical applications show promise for qualifying patients, experts emphasize that improper use of the substance carries severe risks. The drug gained widespread public attention regarding its psychedelic properties following the death of “Friends” actor Matthew Perry, which resulted from acute effects of ketamine abuse.
Did you know?
Clinical Trials and Patient Outcomes
For patients like Crudo, whose daily regimen once included over 20 prescription drugs to cope with a constant pain level rated at 10 out of 10, clinical trials offer an alternative. By pairing the pharmacological effects of the drug with structured psychotherapy, researchers aim to address both the physical neural signals and the psychological toll of long-term suffering. Medical practitioners monitor patients closely during these sessions to evaluate efficacy and ensure safety.
Frequently Asked Questions
What is ketamine approved for in Canada?
Additionally, Health Canada approved esketamine as a prescription nasal spray in 2020 specifically for treatment-resistant depression.
Can ketamine be used for chronic nerve pain?
Yes, medical professionals can administer ketamine off-label in clinical settings for pain management, often alongside psychotherapy as part of specialized clinical trials.
What are the risks associated with ketamine?
Experts warn that improper or recreational use of ketamine can prove fatal, as highlighted by high-profile cases involving substance abuse.
Call to Action: Have you or a loved one explored novel treatments for chronic pain? Share your thoughts in the comments below, or subscribe to our newsletter for the latest updates on medical research and clinical trials.